Brief: Nicox Selects New Drug Candidate For In-House Development Program

Nicox SA

23/10/2020 06:37

Oct 23 (Reuters) - NICOX SA  NCOX.PA :
    * REG-NICOX SELECTS DEVELOPMENT CANDIDATE IN A NEW CLASS OF
NO-MEDIATED INTRAOCULAR PRESSURE (IOP) LOWERING AGENTS
    * NICOX OWNS ALL EXCLUSIVE WORLDWIDE RIGHTS TO NCX 1728
    * NICOX EXPANDS INTERNAL PIPELINE WITH THIRD INNOVATIVE
PROGRAM
    * ANNOUNCES SELECTION OF THIS NEW DRUG CANDIDATE, NCX 1728,
WHICH
BECOMES THIRD IN-HOUSE DEVELOPMENT PROGRAM

Source text for Eikon:  ID:nGNERplbT 
Further company coverage:  NCOX.PA 

 (Gdansk Newsroom)
 ((Gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))